Bristol-Myers Squibb Co. | Cash Flow
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,580
2,029
1,631
4,507
975
4,947
Depreciation, Depletion & Amortization
763
467
376
382
789
637
Other Funds
20
105
2
42
22
94
Funds from Operations
3,057
2,947
2,860
4,210
3,687
5,764
Changes in Working Capital
488
201
1,028
1,360
1,588
176
Net Operating Cash Flow
3,545
3,148
1,832
2,850
5,275
5,940
Capital Expenditures
537
526
820
1,215
1,055
Sale of Fixed Assets & Businesses
9
3,585
708
1,334
722
Purchase/Sale of Investments
44
1,624
349
1,720
975
Net Investing Cash Flow
572
1,216
1,572
1,480
66
Cash Dividends Paid - Total
2,309
2,398
2,477
2,547
2,577
Issuance/Reduction of Debt, Net
1,090
432
1,138
110
991
Net Financing Cash Flow
1,068
2,437
3,351
2,445
4,077
Net Change in Cash
1,930
1,985
3,186
1,852
1,184
Free Cash Flow
3,008
2,622
1,012
1,635
4,220
Deferred Taxes & Investment Tax Credit
491
542
347
204
1,010
86
Net Assets from Acquisitions
-
219
1,111
359
708
Change in Capital Stock
131
288
266
50
2,469
Exchange Rate Effect
25
58
95
33
52
About Bristol-Myers Squibb
View Profile
